HDAC3, a positive regulator of NF-κB-mediated inflammation, inhibits IL-4 induced M2 polarization (121), suggesting HDAC3 inhibition as a potential therapeutic approach for preventing inflammation in COPD (122). Here, HDAC3 is linked to chronic obstructive pulmonary disease.